The Health Research Council of New Zealand (HRC) and PHARMAC have formed a joint research initiative to support innovative research and advance the strategic objectives of both organisations. It is anticipated that this partnership will augment PHARMAC’s focus on securing best health outcomes from pharmaceuticals and build on HRC investment to strengthen the use of research evidence to improve New Zealand’s health system.
The funding partners for this RFP anticipate that successful research projects will target one or more of the following research priority areas. The RFP priority areas listed reflect key challenges facing PHARMAC and the New Zealand health sector where research could make an important contribution:
- improving pharmaceutical adherence
- improving optimal use of pharmaceuticals
- measuring the impact of PHARMAC’s decisions on health outcomes
A total funding pool of approximately $427,500 (exclusive of GST) is available for allocation. The funding partners invite applications for funding of up to $213,750 (exclusive of GST) and duration of up to 24 months.
Applications to this RFP will be submitted via a one-stage process. Applicants are firstly required to submit a registration via the HRC’s online portal HRC Gateway. Registrations are due 1pm, Wednesday 20 July 2016. The full application will need to be submitted via HRC Gateway by 1pm, Wednesday 3 August 2016.
Please refer to the RFP for more information. The RFP, application forms and the application guidelines are available below.
If you have any questions about the PHARMAC and HRC partnership, contact:
Luke Garland, Project Manager
DDI: (09) 303 5214